The Lancet Commission on prostate cancer: planning for the surge in cases

ND James, I Tannock, J N'Dow, F Feng, S Gillessen… - The Lancet, 2024 - thelancet.com
Executive summary Prostate cancer is the most common cancer in men in 112 countries,
and accounts for 15% of cancers. In this Commission, we report projections of prostate …

Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy

JT Wei, D Barocas, S Carlsson, F Coakley… - The Journal of …, 2023 - auajournals.org
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

MRI-targeted or standard biopsy in prostate cancer screening

M Eklund, F Jäderling, A Discacciati… - New England journal …, 2021 - Mass Medical Soc
Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance …

L Emmett, J Buteau, N Papa, D Moon, J Thompson… - European urology, 2021 - Elsevier
Background Multiparametric magnetic resonance imaging (MRI) is validated for the
detection of clinically significant prostate cancer (csPCa), although patients with …

Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study

A Saha, JS Bosma, JJ Twilt, B van Ginneken… - The Lancet …, 2024 - thelancet.com
Background Artificial intelligence (AI) systems can potentially aid the diagnostic pathway of
prostate cancer by alleviating the increasing workload, preventing overdiagnosis, and …

The PRIMARY score: using intraprostatic 68Ga-PSMA PET/CT patterns to optimize prostate cancer diagnosis

L Emmett, N Papa, J Buteau, B Ho… - Journal of Nuclear …, 2022 - jnm.snmjournals.org
Multiparametric MRI (mpMRI) is validated for the diagnosis of clinically significant prostate
cancer (csPCa). 68Ga-PSMA-11 PET/CT (68Ga-PSMA PET/CT) combined with mpMRI has …

Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta …

E Mazzone, A Stabile, F Pellegrino, G Basile… - European urology …, 2021 - Elsevier
Context The variability of the positive predictive value (PPV) represents a significant factor
affecting the diagnostic performance of multiparametric magnetic resonance imaging …

NCCN guidelines® insights: prostate cancer early detection, version 1.2023: featured updates to the NCCN guidelines

KA Moses, PC Sprenkle, C Bahler, G Box… - Journal of the National …, 2023 - jnccn.org
The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for
individuals with a prostate who opt to participate in an early detection program after …

Stimulated Raman scattering microscopy enables gleason scoring of prostate core needle biopsy by a convolutional neural network

J Ao, X Shao, Z Liu, Q Liu, J **a, Y Shi, L Qi… - Cancer …, 2023 - aacrjournals.org
Focal therapy (FT) has been proposed as an approach to eradicate clinically significant
prostate cancer while preserving the normal surrounding tissues to minimize treatment …

Landmarks in the evolution of prostate biopsy

MJ Connor, MA Gorin, D Eldred-Evans, EJ Bass… - Nature Reviews …, 2023 - nature.com
Approaches and techniques used for diagnostic prostate biopsy have undergone
considerable evolution over the past few decades: from the original finger-guided …